These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26528452)

  • 1. Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine.
    Shafie D; Dohaei A; Amin A; Taghavi S; Naderi N
    Res Cardiovasc Med; 2015 Nov; 4(4):e28945. PubMed ID: 26528452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High‑density lipoprotein cholesterol levels and pulmonary artery vasoreactivity in patients with idiopathic pulmonary arterial hypertension.
    Jonas K; Magoń W; Waligóra M; Seweryn M; Podolec P; Kopeć G
    Pol Arch Intern Med; 2018 Aug; 128(7-8):440-446. PubMed ID: 30057380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.
    Cheng XL; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Luo Q; Xiong CM
    Lung; 2016 Aug; 194(4):613-8. PubMed ID: 27272652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension.
    Mahapatra S; Nishimura RA; Sorajja P; Cha S; McGoon MD
    J Am Coll Cardiol; 2006 Feb; 47(4):799-803. PubMed ID: 16487848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical Stimulation-Guided Approach to Pulmonary Artery Catheter Ablation in Patients with Idiopathic Pulmonary Arterial Hypertension: A Pilot Feasibility Study with a 12-Month Follow-Up.
    Goncharova NS; Moiseeva OM; Condori Leandro HI; Zlobina IS; Berezina AV; Malikov KN; Tashkhanov DM; Lebedev DS; Mikhaylov EN
    Biomed Res Int; 2020; 2020():8919515. PubMed ID: 32149144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and survival of Korean idiopathic pulmonary arterial hypertension patients based on vasoreactivity.
    Ahn JH; Kang BJ; Hong SI; Lee JS; Lee JS; Oh YM; Lee SD
    J Korean Med Sci; 2014 Dec; 29(12):1665-71. PubMed ID: 25469067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium channel blockers evaluated by cardiopulmonary exercise testing in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing.
    Tang Y; Yao L; Liu Z; Ma X; Luo Q; Zhao Z; Huang Z; Tu L; Gao L; Jin Q; Ni X; Xiong C
    Pulm Pharmacol Ther; 2017 Apr; 43():26-31. PubMed ID: 28159512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effect of iloprost inhalation and oral sildenafil during acute vasoreactivity test in pulmonary arterial hypertension.
    Sompradeekul S; Wattanasiriphakdee S
    J Med Assoc Thai; 2015 Feb; 98(2):144-9. PubMed ID: 25842794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.
    Leuchte HH; Baezner C; Baumgartner RA; Muehling O; Neurohr C; Behr J
    Heart; 2015 Jun; 101(12):972-6. PubMed ID: 26015441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
    Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
    Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension].
    Jia WB; Jiang X; Zuo XR; He J; Zhao QH; Jiang R; Jing ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):652-6. PubMed ID: 23141008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.
    Sun Y; Li Y; Meng X; Jiang R; Zhao Q; Wang L; Shi L; Luo C; Qiu H; Wu W; Li J; He J; Liu J; Yuan P; Gong S
    Ann Transl Med; 2020 Dec; 8(24):1650. PubMed ID: 33490162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls.
    Farhat N; Cools B; Gewillig M; Seghaye MC; Aggoun Y; Beghetti M
    Front Pediatr; 2019; 7():262. PubMed ID: 31334208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Performance of Pulmonary Capacitance at Rest and During Exercise in Idiopathic Pulmonary Arterial Hypertension.
    Jain P; Rao S; Macdonald P; Kotlyar E; Jabbour A; Hayward C; Keogh A
    Heart Lung Circ; 2019 Feb; 28(2):289-294. PubMed ID: 29150159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
    J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension].
    Fu LJ; Zhou AQ; Guo Y; Zhao PJ; Huang MR; Li F
    Zhonghua Er Ke Za Zhi; 2011 Dec; 49(12):886-9. PubMed ID: 22336352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.